Poland Pharmaceuticals and Healthcare Report Q3 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Poland Pharmaceuticals and Healthcare Report Q3 2013 May 29th 2013, 00:00 BMI View: The Polish pharmaceutical market contracted severely in 2012 due to harsh pricing measures and strict margins imposed on wholesalers, pharmaceutical manufacturers and retailers. Moreover, over the course of the year, the burden of pharmaceutical spending shifted onto the Polish consumer, as the harsher reimbursement regime caused a rise in private contributions to prescription payments. We forecast a return to growth in 2013, driven by demand for hospitals and private consumption growth as the Polish government entrenches cuts to drug expenditure. We expect strong growth in the medium-to-long term as Poland’s economy diversifies and aligns with developed countries. The … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=98784. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/poland-pharmaceuticals-and-healthcare-report-q3-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions